Literature DB >> 10690128

Orexins: a new family of neuropeptides.

D Smart.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10690128     DOI： 10.1093/bja/83.5.695

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN： 0007-0912            Impact factor:   9.166


× No keyword cloud information.
  7 in total

1.  SB-334867-A: the first selective orexin-1 receptor antagonist.

Authors:  D Smart; C Sabido-David; S J Brough; F Jewitt; A Johns; R A Porter; J C Jerman
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

Review 2.  Obesity and chronic daily headache.

Authors:  Marcelo E Bigal; Alan M Rapoport
Journal:  Curr Pain Headache Rep       Date:  2012-02

3.  The hypocretins are weak agonists at recombinant human orexin-1 and orexin-2 receptors.

Authors:  D Smart; J C Jerman; S J Brough; W A Neville; F Jewitt; R A Porter
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

4.  Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPR.

Authors:  D Smart; J C Jerman; S J Brough; S L Rushton; P R Murdock; F Jewitt; N A Elshourbagy; C E Ellis; D N Middlemiss; F Brown
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

Review 5.  Cluster headache, hypothalamus, and orexin.

Authors:  Philip R Holland; Peter J Goadsby
Journal:  Curr Pain Headache Rep       Date:  2009-04

6.  Microelectrode recording in the posterior hypothalamic region in humans.

Authors:  Sepehr Sani; Shoichi Shimamoto; Robert S Turner; Nadja Levesque; Philip A Starr
Journal:  Neurosurgery       Date:  2009-03       Impact factor: 4.654

7.  Characterisation of the binding of [3H]-SB-674042, a novel nonpeptide antagonist, to the human orexin-1 receptor.

Authors:  Christopher J Langmead; Jeffrey C Jerman; Stephen J Brough; Claire Scott; Rod A Porter; Hugh J Herdon
Journal:  Br J Pharmacol       Date:  2003-12-22       Impact factor: 8.739
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.